Tag: Diabetes

Essential Vision Care for Older Adults with Medicare Advantage Plans

Discover essential vision care for older adults under Medicare Advantage plans, emphasizing screenings for cataracts and diabetic retinopathy.

Trends in Diabetic Retinal Disease Among Diabetes Patients: Implications for Insurance

Analyze recent trends in diabetic retinal disease affecting patients and implications for insurance care models, risk management, and enhanced patient outcomes.

Efforts to Cap Insulin Costs Continue Amid Ongoing Challenges

Bipartisan efforts to cap insulin costs at $35/month for insured individuals align with rising advocacy for affordable diabetes management. Urgent change needed now.

Proposed $35 Insulin Cap Under Private Insurance Highlights Financial Burdens

Explore proposed legislation aiming to cap insulin costs at $35, addressing financial burdens on families managing diabetes. Current healthcare challenges assessed.

OHSU Study Reveals Health Risks for Diabetic Patients Losing Insurance

Study from OHSU links health insurance loss to poor diabetes management, urging improved support for community health and Medicaid policy reform.

Medicare Diabetes Prevention Program Expands Access through Federal Policy

Explore how recent federal policy changes enhance access to the Medicare Diabetes Prevention Program, promoting health for older adults at risk of diabetes.

Rise in CGM Adoption Among Medicare Advantage Enrollees with Diabetes

Discover a rise in CGM adoption among Medicare enrollees with diabetes, enhancing management and access by 2026 with no out-of-pocket costs.

Understanding Life Insurance Underwriting for Diabetics

Discover how life insurance underwriting for diabetics has evolved, including new rates and criteria that benefit well-managed diabetes patients.

ECU Health Launches Diabetes Management Community Program

Discover ECU Health's diabetes program empowering individuals with practical self-care strategies for better lifestyle management. Enroll today!

Eli Lilly's Mounjaro Added to China's National Health Insurance Program

Eli Lilly's diabetes drug Mounjaro is set to be included in China's national health insurance reimbursement list, boosting accessibility but with potential revenue impact from pricing adjustments.